Perceptive Xontogeny Venture Fund, LP
Related Filers (13)
- PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (19)
- EDELMAN JOSEPH (19)
- PERCEPTIVE ADVISORS LLC (19)
- Perceptive Venture Advisors, LLC (7)
- Astria Therapeutics, Inc. (6)
- LianBio (6)
- LEV LB Holdings GP, LLC (6)
- LEV LB Holdings, LP (6)
- C2 Life Sciences LLC (6)
- Xontogeny, LLC (5)
- Landos Biopharma, Inc. (5)
- Solid Biosciences Inc. (2)
- Perceptive Xontogeny Venture Fund II, LP (1)
- Show More ...
Other (2)
D/A
Tuesday, 11/26/2019
Exempt (Private) Offering
D
Wednesday, 11/28/2018
Exempt (Private) Offering
Ownership (19)
4
Monday, 2/5/2024
Astria Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/12/2024
Solid Biosciences Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/22/2023
Astria Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/18/2023
Astria Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/11/2023
Landos Biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/21/2022
Astria Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/6/2022
Solid Biosciences Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/22/2022
LianBio: Statement of changes in beneficial ownership of securities
4
Friday, 5/27/2022
LianBio: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/25/2022
LianBio: Statement of changes in beneficial ownership of securities
4
Friday, 11/5/2021
LianBio: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/3/2021
LianBio: Statement of changes in beneficial ownership of securities
3
Friday, 10/29/2021
LianBio: Initial statement of beneficial ownership of securities
4
Tuesday, 8/31/2021
Landos Biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/9/2021
Landos Biopharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/8/2021
Landos Biopharma, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/3/2021
Landos Biopharma, Inc.: Initial statement of beneficial ownership of securities
3
Wednesday, 2/3/2021
CATABASIS PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
4
Wednesday, 2/3/2021
CATABASIS PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities